Kidney Transplantation
Part of NephTimes
Researchers in China announced that they have performed a successful transplant of a gene-edited pig kidney into a patient. Suphamai Bunnapradist discussed the phase 3 TRANSCEND study of felzartamab to treat late AMR after kidney transplantation. NOBLE examined the efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent C3G or IC-MPGN. Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D. The American Kidney Fund's Living Donor Report Card found that many US states lack protections for living kidney donors. Eledon Pharmaceuticals CEO David-Alexandre Gros, MD, spoke about the role of CD40L blocker tegoprubart in transplantation. The KidneyVault Portable Renal Perfusion System has been used in human kidney transplants for the first time. The NKF will invest in the NoMo Kidney Pump, a continuous perfusion system to modernize kidney preservation and storage. Current eligibility criteria for simultaneous heart and kidney transplantation may be subject to eGFRcr errors. An analysis sought to determine the economic costs of treating SARS-CoV-2 infection among kidney transplant recipients. The FDA has granted United Therapeutics approval to begin a first-in-human clinical study of a gene-edited pig kidney. A study examined the safety and noninferiority of kidney transplantation from donors with HIV to recipients with HIV. A systematic review and meta-analysis evaluated the safety of statin use among kidney allograft recipients. Is time to death from withdrawal of life-sustaining treatment is associated with kidney transplant outcomes? The TRANSNEMIA study addressed the need for guidelines specific to anemia in kidney transplant recipients. The American Kidney Fund is providing emergency financial aid to patients impacted by the California wildfires. CERTAIN registry data were used to assess age-related differences in outcomes among pediatric kidney transplant recipients. Researchers studied the clinical relevance of allograft microvascular inflammation in kidney transplantation. Development of a transplant morbidity gene panel highlights how genetic testing could open the door to personalized care. Researchers studied outcomes of transplant recipients who received kidneys from toxoplasma-positive versus negative donors.